Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
R. R. Holman, S. Paul, A. Farmer, L. Tucker, I. M. Stratton, H. A. W. Neil, on behalf of the AFORRD study groupVolume:
52
Language:
english
Pages:
10
DOI:
10.1007/s00125-008-1179-5
Date:
January, 2009
File:
PDF, 207 KB
english, 2009